Clinical Trial: Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07656493) titled 'Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients' on June 05.

Brief Summary: This real-world observational study aims to evaluate the effectiveness and safety of liposomal amphotericin B (L-AmB) in solid organ transplant recipients with invasive fungal disease (IFD). IFD is a major cause of morbidity and mortality in transplant recipients because of long-term immunosuppressive therapy and increased susceptibility to opportunistic fungal infections.

This is a single-center ambispective cohort study conducted at Sichuan Provincial People's Hospital. The study includes a prospective cohort of s...